O
AGN.PRA

OrbiMed’s Allergan plc AGN.PRA Stock Holding History

OrbiMed’s Portfolio AGN.PRA Stock Details AGN.PRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Hold
0
– – – 59
2017
Q3 		– Hold
0
– – – 49
2017
Q2 		– Sell
-88,200
Closed -$73.9M – 42
2017
Q1 		$74.8M Buy
+88,200
New +$73.1M 0.85% 40
2016
Q4 		– Sell
-88,200
Closed -$66.7M – 39
2016
Q3 		$72.5M Buy
+88,200
New +$76.2M 0.83% 48
2016
Q2 		– Sell
-104,200
Closed -$87M – 39
2016
Q1 		$95.8M Hold
104,200
– – 1.01% 32
2015
Q4 		$107M Hold
104,200
– – 0.97% 34
2015
Q3 		$98.3M Hold
104,200
– – 0.99% 37
2015
Q2 		$109M Buy
+104,200
New +$109M 0.91% 34

Other funds holding AGN.PRA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
WAM
Weiss Asset Management Boston, Massachusetts $5.91B AUM 42.42% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Calamos Advisors
Calamos Advisors Naperville, Illinois $28.2B AUM 21.78% 1-Year Est. Return
ES
Equitec Specialists Chicago, Illinois $708K AUM 25.27% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

OrbiMed's AGN.PRA Position: Q4 2017 in Review

OrbiMed held its Allergan plc (AGN.PRA) position steady in Q4 2017 at 0 shares worth $42M. The position accounts for 0.53% of the portfolio, ranked #59.

OrbiMed first reported a position in AGN.PRA in Q2 2015 and has held it in 6 quarters since. The position peaked at $109M in Q2 2015. 90 funds tracked by Wall St. Rank hold AGN.PRA as of Q4 2017.

  • OrbiMed held 0 shares of Allergan plc worth $42M as of Q4 2017.
  • OrbiMed left its Allergan plc share count unchanged in Q4 2017.
  • Allergan plc made up 0.53% of OrbiMed's portfolio in Q4 2017, its #59 holding.
  • OrbiMed first reported a position in Allergan plc in Q2 2015 and has held it in 6 quarters since.
  • OrbiMed's Allergan plc position peaked at $109M in Q2 2015.
  • 90 funds tracked by Wall St. Rank held Allergan plc as of Q4 2017.

Based on OrbiMed's 13F filing for Q4 2017, filed 14 Feb 2018.